Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. ×òî-òî íàøëè... Àòèïè÷íàÿ ðåàêòèâèçàöèÿ ÂÝÁ
    îò neznaj â ðàçäåëå Èíôåêöèîííûå áîëåçíè
    Îòâåòîâ: 119
    : 26.07.2005, 12:27
  2. Àòèïè÷íûå êëåòêè
    îò Êëîòèëüäà â ðàçäåëå Ãèíåêîëîã-àêóøåð, áåðåìåííîñòü, ðîäû
    Îòâåòîâ: 10
    : 13.04.2005, 19:06
  3. Ïðî àòèïè÷íûå òðèõîìîíàäû
    îò Çîÿ Àâäååâà â ðàçäåëå Äëÿ ìåäèêîâ è ôàðìàöåâòîâ
    Îòâåòîâ: 35
    : 01.09.2004, 19:30
  4. Îòâåòîâ: 3
    : 16.07.2004, 20:26
  5. Àòèïè÷íàÿ ïíåâìîíèÿ
    îò rrh â ðàçäåëå Èíôåêöèîííûå áîëåçíè
    Îòâåòîâ: 2
    : 15.05.2003, 17:51
  1. imported_ÊÀ
    #31
    ×èòàòåëü Íåäóã.Ðó
    to Dot: Êàêîé 1 Ìåä? Ïèòåð èëè Ìîñêâà?

  2. Áèëèê
    #32
    ×èòàòåëü Íåäóã.Ðó
    Ìîñêâà

  3. Mikhail
    #33
    ×èòàòåëü Íåäóã.Ðó
    Elf,


    "Íî â êðîâè íå áûëî èçìåíåíèé, õàðàêòåðíûõ äëÿ ÂÝÁ." - ïîâûøåííîãî êîëè÷åñòâà ìîíîíóêëåàðîâ?


    "...ìîæåò ïðîñòî ãåðïåñ áûë, êîò. ñðåàãèðîâàë íà ÏÖÐ" - ÷åñòíî ãîâîðÿ îá ýòîì è ìíå ïîäóìàëîñü...


    "...ÿ ïîñòàâèë ñàì ñåáå ÏÖÐ íà ÂÈ×, ïîñëå ÷åãî ìîÿ ôîáèÿ ïåðåøëà íà ñîâåðøåííî èíîé óðîâåíü." - ïîëó÷èë ïëþñ??


    Íàâåðíÿêà ìîæåò áûòü ëîæíûì, âåäü ÏÖÐ æå...

  4. kamin
    #34
    ×èòàòåëü Íåäóã.Ðó
    Ñèìåí,





    Ðàçãîâîð èäåò ïðî ÏÖÐ äëÿ ÂÝÁ. ß âîò íå çíàþ, áûëè ó ìåíÿ èçìåíåíèÿ â êðîâè âî âðåìÿ îñòðîé ñòàäèè áîëåçíè. ß äàæå òîëêîì íå çíàþ êîãäà ýòî îñòðàÿ ñòàäèÿ áûëà, òàê êàê áûëî âñå âåñüìà ðàçìàçàíî, à ËÓ íàäêëþ÷å÷íûå ÿ îáíàðóæèë ñëó÷àéíî, à ïîòîì òàêæå ñëó÷àéíî ÷òî èõ óæå íåò...





    Ìåíÿ íåìíîãî íàñòîðàæèâàåò, ÷òî ìíå ïîñòàâëåí äèàãíîç àòèïè÷íàÿ ðåàêòèâàöèÿ. Ó ìåíÿ åñòü ðîäñòâåííèê, ðàáîòàþùèé â êëèíè÷åñêîé áîëüíèöå. ß ïîïðîñèë ïåðåäàòü ðåçóëüòàòû ìîåãî àíàëèçà èíôåêöèîíèñòó, äëÿ àëüòåðíàòèâíîãî ìíåíèÿ. ß â÷åðà ÷òî-òî çà÷èòàëñÿ ïðî ÂÝÁ è íàøåë ìíîãî èíòåðåñíîãî è ñòðàøíîãî. Íàïðèìåð, ÷òî ïðè èíôèöèðîâàíèè, ÂÈ× ìîæåò àêòèâèçèðîâàòü ÂÝÁ èëè ïðèâîäèòü ê òîìó, ÷òî â êðîâè áóäóò îáíàðóæèâàòüñÿ àòèïè÷íûå ìîíîíóêëåàðû, ÷òî ìîæåò ïðèâåñòè ê èçìåíåíèþ èëè ïîÿâëåíèþ (òàê è íå ïîíÿë) àíòèòåë ê ÂÝÁ.


    Âîîáùå ñîñòîÿíèå àòèïè÷íîé ðåàêòèâàöèè íàçûâàåòñÿ ñîñòîÿíèå - êîãäà IgM VCA è IgG NA-1 ïîëîæèòåëüíû, â òî âðåìÿ êàê Ig EA îòñóòñòâóåò. Çäåñü áû êîíå÷íî õîòåëîñü áû ïîëó÷èòü êîíñóëüòàöèþ ñïåöèàëèñòà...  ìîåì ñëó÷àå ìîæåò íàñòîðàæèâàòü òîëüêî òîò ôàêò, ÷òî òèòð (ÎÏ) IgG NA-1 âûñîêèé, íî ñ äðóãîé ñòîðîíû âðåìåíè óæå ïðîøëî ìíîãî (2-3 ìåñÿöà), è îí (òèòð) ìîã ïîäíÿòüñÿ... IgM ìîæåò äî ñèõ ïîð áûòü íåçíà÷èòåëüíî ïîëîæèåòåëüíûì (0.1), òàê êàê çàáîëåâàíèå çàêîí÷èëîñü íå òàê óæ è äàâíî... ß íå çíàþ áûë ëè äî ýòîãî ó ìåíÿ ÂÝÁ èëè íåò... È òàêæå íå ïîíèìàþ, íà îñíîâàíèè ÷åãî áûëî ñäåëàíî çàêëþ÷åíèå àíàëèçà - àòèïè÷íàÿ ðåàêòèâàöèÿ... Ìîæåò çàïëà÷ó äåíåã è âñå-òàêè ñõîæó íà ïðèåì ê âðà÷ó â ÍÈÈ èììóíîëîãèè...





    À âîîáùå ÂÝÁ - ÷åì-òî ñðîäè ÑÏÈÄó. Òîæå ïîäñàæèâàåò èììóíîé ñèñòåìó - ïðè÷åì íå ïî äåòñêè...

  5. imported_Åëåíà Ã.
    #35
    ×èòàòåëü Íåäóã.Ðó
    Seamen,


    Äà, íå áûëî àòèïè÷íûõ ìîíîíóêëåàðîâ. Íàñ÷åò ãåðïåñà - íå çíàþ, õîòÿ ãåðïåñ îíè òîæå ñòàâèëè, íî ãåðïåñ íå íà÷èíàåòñÿ ñ ñûïè,óâåë. ë.ó, òåì-ðû.


     îòíîøåíèè ÂÈ× ñàì íå çíàþ. Ïðàéìåðû ïîäáèðàë íå ÿ, âçÿë èç ñòàòüè. Ñíà÷àëà ïîëó÷èë "+", ïîòîì "-". Ñìîòðåë ïðîâèðóñíóþ ÐÍÊ. Åäèíñòâåííîå, ÷òî óñïîêàèâàåò, ÷òî ïîêà ìîé "+" íèãäå íå áûë ïîäòâåðæäåí, äà è ðåç-òû ìîèõ ïîçäíèõ ÏÖÐ íå âûÿâèëè íè îäíîé ïîñëåäîâàòåëüíîñòè, õàðàêòåðíîé äëÿ ÂÈ×. Íî åñòü åùå îäíà ïðîáëåìà-ÿ ðàáîòàë ñ ðåòðîâèðóñàìè.  ïðèíöèïå îíè äîëæíû áûòü íå ñïîñîáíû ê ðåïëèêàöèè.Íî...

  6. Äîêòîð Øóðà
    #36
    ×èòàòåëü Íåäóã.Ðó
    Íåêòî,


    íàñ÷åò òîãî, ÷òî ÂÝÁ ñðîäíè ÑÏÈÄ - ýòî òû õâàòèë... Õîòÿ Ñèíäðîì Õðîíè÷åñêîé Óñòàëîñòè âïîëíå ìîæåò âûçâàòü è èììóíêó ñàäèò è äàæå ñåëåçåíêó ñ ïå÷åíüþ ðàçîðâàòü ìîæåò... Íî âñå æå íå òî...


    Íàñ÷åò àëüòåðíàòèâíîãî ìíåíèÿ - î÷åíü çäðàâàÿ ìûñëü. Íå çíàþ, ïðàâäà, ÷åì òåáå ïîìîæåò ïîõîä â ÍÈÈ Èììóíîëîãèè, íî êîíñóëüòàöèÿ ñ õîðîøèì ñïåöèàëèñòîì òî÷íî íå ïîâðåäèò. Ïðîñòî áîþñü, ÷òî âñå æå âñå ðàâíî íè÷åãî ýòî íå ïðîÿñíèò. Äàé Áîã ÷òîá îøèáàëñÿ... Õîòÿ ÿ íå ñïåöèàëèñò, à âñåãî ëèøü "ëþáèòåëü" ïîíåâîëå , íî ìíå òîæå êàæåòñÿ, ÷òî èìåííî ïðî àòèïè÷íóþ ðåàêòèâàöèþ íè÷åãî òîëêîì íå ãîâîðèò. Ñêîðåå ïîõîæå íà íà÷àëî ïàñò èíôåêöèè... Âîîáùå ìîæåò ÷òî-òî ïðîÿñíèòü àíàëèç íå íà 3, à íà 4 ìàðêåðà, õîòÿ è íåîáÿçàòåëüíî.


    Âîîáùåì íèæå òåáå ïðèâåäó äîâîëüíî äåëüíóþ èíôó ïî ëàáîðàòîðíîé äèàãíîñòèêå ÂÝÁ è, ÷òî èíòåðåñíî, ïî èíòåðïðåòàöèè ðåçóëüòàòîâ. Òàì ïðàâèëüíî ñêàçàíî, ÷òî ýòî íå foolproof...


    (èíôà ñ CDC):





    DIAGNOSIS OF EBV INFECTIONS





    In most cases of infectious mononucleosis, the clinical diagnosis can be made from the characteristic triad of fever, pharyngitis, and lymphadenopathy lasting for 1 to 4 weeks. Serologic test results include a normal to moderately elevated white blood cell count, an increased total number of lymphocytes, greater than 10% atypical lymphocytes, and a positive reaction to a "mono spot" test. In patients with symptoms compatible with infectious mononucleosis, a positive Paul-Bunnell heterophile antibody test result is diagnostic, and no further testing is necessary. Moderate-to-high levels of heterophile antibodies are seen during the first month of illness and decrease rapidly after week 4. False-positive results may be found in a small number of patients, and false-negative results may be obtained in 10% to 15% of patients, primarily in children younger than 10 years of age. True outbreaks of infectious mononucleosis are extremely rare. A substantial number of pseudo-outbreaks have been linked to laboratory error, as reported in CDC's Morbidity and Mortality Weekly Report, vol. 40, no. 32, on August 16, 1991.





    When "mono spot" or heterophile test results are negative, additional laboratory testing may be needed to differentiate EBV infections from a mononucleosis-like illness induced by cytomegalovirus, adenovirus, or Toxoplasma gondii. Direct detection of EBV in blood or lymphoid tissues is a research tool and is not available for routine diagnosis. Instead, serologic testing is the method of choice for diagnosing primary infection.





    EBV-Specific Laboratory Tests


    Laboratory tests are not always foolproof. For various reasons, false-positive and false-negative results can occur for any test. However, the laboratory tests for EBV are for the most part accurate and specific. Because the antibody response in primary EBV infection appears to be quite rapid, in most cases testing paired acute- and convalescent-phase serum samples will not demonstrate a significant change in antibody level. Effective laboratory diagnosis can be made on a single acute-phase serum sample by testing for antibodies to several EBV-associated antigens simultaneously. In most cases, a distinction can be made as to whether a person is susceptible to EBV, has had a recent infection, has had infection in the past, or has a reactivated EBV infection.





    Antibodies to several antigen complexes may be measured. These antigens are the viral capsid antigen, the early antigen, and the EBV nuclear antigen (EBNA). In addition, differentiation of immunoglobulin G and M subclasses to the viral capsid antigen can often be helpful for confirmation. When the "mono spot" test is negative, the optimal combination of EBV serologic testing consists of the antibody titration of four markers: IgM and IgG to the viral capsid antigen, IgM to the early antigen, and antibody to EBNA.





    IgM to the viral capsid antigen appears early in infection and disappears within 4 to 6 weeks. IgG to the viral capsid antigen appears in the acute phase, peaks at 2 to 4 weeks after onset, declines slightly, and then persists for life. IgG to the early antigen appears in the acute phase and generally falls to undetectable levels after 3 to 6 months. In many people, detection of antibody to the early antigen is a sign of active infection, but 20% of healthy people may have this antibody for years.





    Antibody to EBNA determined by the standard immunofluorescent test is not seen in the acute phase, but slowly appears 2 to 4 months after onset, and persists for life. This is not true for some EBNA enzyme immunoassays, which detect antibody within a few weeks of onset.





    Finally, even when EBV antibody tests, such as the early antigen test, suggest that reactivated infection is present, this result does not necessarily indicate that a patient's current medical condition is caused by EBV infection. A number of healthy people with no symptoms have antibodies to the EBV early antigen for years after their initial EBV infection.





    Therefore, interpretation of laboratory results is somewhat complex and should be left to physicians who are familiar with EBV testing and who have access to the entire clinical picture of a person. To determine if EBV infection is associated with a current illness, consult with an experienced physician.





    Additional Information about EBV Antibody Tests and Interpretation


    Antibody tests for EBV can measure the presence and/or the concentration of at least six specific EBV antibodies. By evaluating the results of these different tests, the stage of EBV infection can be determined. However, these tests are expensive and not usually needed for the diagnosis of infectious mononucleosis.





    It is not appropriate for CDC to interpret test results or to handle counseling for the public. We suggest that questions be directed to a local physician who is familiar with the patient's history and laboratory test results. In addition, CDC cannot recommend specific physicians for referral. Our general recommendation is for patients to consult with an infectious disease specialist or their local or state public health department.





    SUMMARY OF INTERPRETATION





    The diagnosis of EBV infection is summarized as follows:





    Susceptibility


    If antibodies to the viral capsid antigen are not detected, the patient is susceptible to EBV infection.





    Primary Infection


    Primary EBV infection is indicated if IgM antibody to the viral capsid antigen is present and antibody to EBV nuclear antigen, or EBNA, is absent. A rising or high IgG antibody to the viral capsid antigen and negative antibody to EBNA after at least 4 weeks of illness is also strongly suggestive of primary infection. In addition, 80% of patients with active EBV infection produce antibody to early antigen.





    Past Infection


    If antibodies to both the viral capsid antigen and EBNA are present, then past infection (from 4 to 6 months to years earlier) is indicated. Since 95% of adults have been infected with EBV, most adults will show antibodies to EBV from infection years earlier. High or elevated antibody levels may be present for years and are not diagnostic of recent infection.





    Reactivation


    In the presence of antibodies to EBNA, an elevation of antibodies to early antigen suggests reactivation. However, when EBV antibody to the early antigen test is present, this result does not automatically indicate that a patient's current medical condition is caused by EBV. A number of healthy people with no symptoms have antibodies to the EBV early antigen for years after their initial EBV infection. Many times reactivation occurs subclinically.





    Chronic EBV Infection


    Reliable laboratory evidence for continued active EBV infection is very seldom found in patients who have been ill for more than 4 months. When the illness lasts more than 6 months, it should be investigated to see if other causes of chronic illness or CFS are present.





    Íàäåþñü ýòî ÷åì-òî ïîìîæåò.

  7. VadimP
    #37
    ×èòàòåëü Íåäóã.Ðó
    Âàñ ïî ðóññêè òî óæå íå ïîíÿòü, à òóò åùå è íà àíãëèöêîì... Ìîæåò ïîïðîùå, à?

  8. Ìèëëà
    #38
    ×èòàòåëü Íåäóã.Ðó
    Dot, íó íå ïåðåâîäèòü æå??? Íåêòî è òàê ïîéìåò, îí âñåÿäíûé

  9. s_v
    #39
    ×èòàòåëü Íåäóã.Ðó
    Elf,


    èçâèíè, åñëè ÿ ñî ñâîèìè ñêðîìíûìè ïîçíàíèÿìè ïîïðîáóþ âûñêàçàòü ñâîå ìíåíèå...


     îòíîøåíèè ÂÈ×. Ïîíÿòíîå äåëî, ÷òî òû ñòàâèë åùå ÏÖÐ è íå ðàç. Ñêîðåå âñåãî, åñëè áû ïåðâûé áûë íå ëîæíûì, òî è îñòàëüíûå áû åãî ïîäòâåðäèëè, åñëè òû êîíå÷íî íå ïðèíèìàë òåðàïèþ. Êñòàòè êàêóþ íàãðóçêó ïîêàçàë ïåðâûé? Åñëè íå âûñîêóþ, òî ýòî ãîâîðèò åùå áîëüøå â ïîëüçó ËÏÐ. Õîòÿ âðà÷àì íå ðåêîìåíäóåòñÿ ïûòàòüñÿ ñòàâèòü ñàìîñòîÿòåëüíî ñåáå äèàãíîç, íî ìîæåò ñòàâèòü àíàëèç è ìîæíî . Íó õîðîøî, äîïóñòèì ñ ïðàéìåðàìè áûëî âñå â íîðìå, íî êàêîâà ãàðàíòèÿ òîãî, ÷òî ñëó÷àéíî íå ïîïàëî ïàðó ìîëåêóë îò ïðîäóêòîâ àìïëèôèêàöèè ïðåäûäóùèõ àíàëèçîâ? Êòî îò ýòîãî çàñòðàõîâàí íà 100%? Õîòÿ ïîíèìàþ, êëèíèêà...


    Íî âåäü íå îäíè æå ÂÈ× è ÝÁ òàêóþ êëèíèêó ìîãóò äàâàòü! Åñëè íåò ìàðêåðîâ ÝÁ è íå áûëî ïîâûøåííîãî êîëè÷åñòâà àòèïè÷íûõ ìîíîíóêëåàðîâ, òî âñå æå ñêîðåå âñåãî ýòî íå ÝÁÂ. Ìîæåò âñå æå êðîññ-ðåàêöèÿ íà ãåðïåñ?


    Äîïóñòèì ñòàâèëè àíàëèç ñêîðåå âñåãî íà HSV1/2 è íå íàøëè, íî âåäü ïîëíî åùå ãåðïåñîâ. Íàïðèìåð HHV-8. Ïî÷òè óâåðåí, ÷òî íå ïðîâåðÿëñÿ...


    À ÷òî íàñ÷åò ðàáîòû ñ ðåòðîâèðóñàìè?  ýòîì çàêëþ÷àåòñÿ òâîé ðèñê?


    Ó ìåíÿ, ïðèçíàòüñÿ, òîæå êàêàÿ-òî ñòðàííàÿ êëèíèêà (ñûïü,ë/ó,òåìïåðàòóðà ) è íå ïîõîæå, ÷òîáû â ýòîì áûë âèíîâàò ÝÁÂ, äà è ÂÈ×à òîæå íåò, åñëè ýòî êîíå÷íî íå êàêîé-òî íåèçâåñòíûé íàóêå øòàìì (èäè çíàé ÷òî ìîæíî èç Àôðèêè ïðèâåçòè... ). Ïîýòîìó ìåíÿ âñå ÷àùå ñåðüåçíî ïîñåùàþò ìûñëè: "À íå ñäàòüñÿ ëè íà HTLV1/2?"


    Åñëè áóäåò æåëàíèå, íàïèøè ìíå íà ìûëî. Î÷åíü áûëî áû èíòåðåñíî ïîîáùàòüñÿ...

  10. Nartkala
    #40
    ×èòàòåëü Íåäóã.Ðó
    Íåêòî - druzok, uspokoisia! Indikatornix zabolevanii HIV ne sushestvuet, sushestvuut indikatornie zabolevanija AIDS, no i po nim diagnoz ne staviat.

  11. Àñèÿ
    #41
    ×èòàòåëü Íåäóã.Ðó
    Óðààà! SIFON âåðíóëñÿ! Ïðèâåò äðóæèùå!

  12. elso1
    #42
    ×èòàòåëü Íåäóã.Ðó
    Äà, Íåêòî, ÷óòü íå çàáûë. Êîíå÷íî íà ôîíå ñíèæåíèÿ êîëè÷åñòâà Ò-êëåòî÷åê ïðè îñòðîé ñòàäèè ÂÈ×-èíôåêöèè ìîãóò âûëåçàòü âñÿêèå ãåðïåñû-êàíäèäû è ÂÝÁ â òîì ÷èñëå, íî âåäü òû ñäàë ÈÔÀ äíåé ÷åðåç 10 ïîñëå òîãî, êàê âñå çàêîí÷èëîñü è òû ñåáÿ óæå õîðîøî ÷óâñòâîâàë. Çíà÷èò ïî ëîãèêå âåùåé, åñëè áû áûë ÂÈ×, òî àíòèòåëà áû óæå äîëæíû áûëè îáíàðóæèòüñÿ. Ê òîìó æå è ñðîê ó òåáÿ áûë ïðèëè÷íûé óæå äëÿ ýòîãî. ß äåéñòâèòåëüíî ÷èòàë, ÷òî ïðè ÎÑ ÂÈ× ìîãóò èíîãäà ïîÿâëÿòüñÿ â êðîâè â áîëüøîì êîëè÷åñòâå àòèïè÷íûå ìîíîíóêëåàðû, ÷òî ñáèâàåò ñ òîëêó è ìîæåò ïðèâîäèòü ê îøèáî÷íîìó äèàãíîçó - Ìîíî, íî âîò ÷òîáû ïîÿâëÿëèñü àíòèòåëà ê ÂÝÁ, êîãäà åãî íåò - ýòî óæå ñëèøêîì...


    Ñàì ïîäóìàé.

  13. Ëåîíà
    #43
    ×èòàòåëü Íåäóã.Ðó
    Privet SEAMAN Rad tebia videt'.

  14. Dana
    #44
    ×èòàòåëü Íåäóã.Ðó
    È ÿ ðàä. Êàêèìè ñóäüáàìè?

  15. bezm
    #45
    ×èòàòåëü Íåäóã.Ðó
    Prosto zashel pochitat'...Bil zaniat rabotoi v poslednie dni.

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •